Global Advisory Committee on Vaccine Safety,3-4 December 2009.
D000293:Adolescent; D000328:Adult; D001500:BCG Vaccine / Q000009:adverse effects / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control; D016903:Drug Monitoring; D015658:HIV Infections / Q000276:immunology; D006801:Humans; D007223:Infant; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D008585:Meningitis, Meningococcal / Q000517:prevention & control; D014376:Tuberculosis / Q000517:prevention & control; D014612:Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D018074:Vaccines, Conjugate / Q000009:adverse effects / Q000627:therapeutic use; D014944:World Health Organization; D055815:Young Adult
D001500:BCG Vaccine; D001428:Bacterial Vaccines; D007252:Influenza Vaccines; D014612:Vaccines; D018074:Vaccines, Conjugate